Patents Assigned to LUYE PHARMA AG
  • Transdermal therapeutic system with an overtape comprising two adhesive layers
    Patent number: 11013697
    Abstract: The present invention relates to a transdermal therapeutic system for administration of an active ingredient and a process for the preparation thereof. The transdermal therapeutic system comprises an overtape with two adhesive layers.
    Type: Grant
    Filed: March 14, 2016
    Date of Patent: May 25, 2021
    Assignee: Luye Pharma AG
    Inventors: Björn Schurad, Marieke Gosau
  • Lattice loss reduction
    Patent number: 10758495
    Abstract: Methods for producing systems for the transdermal or permucosal administration of active substances and particularly transdermal therapeutic systems (TTS), wherein the active substance depots thereof have a shape that deviates from a rectangular design.
    Type: Grant
    Filed: January 21, 2013
    Date of Patent: September 1, 2020
    Assignee: Luye Pharma AG
    Inventors: Ludwig Grader, Holger Piotrowski
  • Device for the manufacture of pharmaceutical patches
    Patent number: 10759076
    Abstract: The present invention relates to a device for the manufacture of pharmaceutical patches, a method for the manufacture of pharmaceutical patches, and a package comprising a pharmaceutical patch obtainable by said method.
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: September 1, 2020
    Assignee: Luye Pharma AG
    Inventors: Ludwig Grader, Holger Piotrowski
  • Transdermal therapeutic system for administering an active substance
    Patent number: 10660863
    Abstract: The present invention relates to a transdermal therapeutic system for administering an active substance through the skin, said system being suitable for an application period of at least three days, comprising the layers arranged in the following order with respect to each other: a) a cover layer, b) an active substance layer comprising a polymer matrix containing the active substance, c) an adhesive layer comprising a contact adhesive, which consists of a mixture of one or more polyisobutylenes and one or more polybutenes, and d) a pull-off layer.
    Type: Grant
    Filed: December 14, 2011
    Date of Patent: May 26, 2020
    Assignee: Luye Pharma AG
    Inventors: Britta Langer, Björn Schurad, Heike Prinz
  • Transdermal therapeutic system for administering rivastigmine or derivatives thereof
    Patent number: 10076502
    Abstract: The present invention relates to a transdermal therapeutic system for administering an active substance through the skin, comprising: a) a cover layer, b) a reservoir present on the cover layer, comprising a polymer matrix comprising the active substance, c) an adhesive layer present on the reservoir comprising a contact adhesive, and d) a removable layer present on the adhesive layer, the active substance being rivastigmine, a physiologically compatible salt, hydrate, solvate or derivative thereof, characterized in that the polymer matrix of the reservoir comprises neither hydroxyl groups nor carboxyl groups.
    Type: Grant
    Filed: December 19, 2014
    Date of Patent: September 18, 2018
    Assignee: Luye Pharma AG
    Inventors: Heike Prinz, Bjorn Schurad, Thomas Beckert, Kristina Linder
  • Implant cannula having an implant and a method for securing implants in an injection cannula
    Patent number: 9616212
    Abstract: The application provides an injection cannula having an implant which is detachably secured in the cannula. The application also provides a method for detachably securing an implant in an injection cannula.
    Type: Grant
    Filed: February 17, 2011
    Date of Patent: April 11, 2017
    Assignee: LUYE PHARMA AG
    Inventor: Heiko Spilgies